Thromboelastography in Patients with Inflammatory Bowel Disease

Area of Science:

• Gastroenterology
• Hematology
• Clinical Chemistry

Background:

• Inflammatory bowel disease (IBD), encompassing Crohn's disease (CD) and ulcerative colitis (UC), is associated with an increased risk of venous thromboembolic events (VTEs).
• Disease activity in IBD correlates with a higher incidence of VTEs, necessitating the identification of predictive markers and effective prophylactic strategies.
• Understanding the hemostatic profile in IBD patients is crucial for managing VTE risk.

Purpose of the Study:

• To identify novel thrombophilic markers in Chinese patients with IBD using thromboelastography (TEG).
• To evaluate the relationship between predisposing factors, disease activity, and hemostatic changes in Crohn's disease and ulcerative colitis.
• To assess the utility of TEG parameters in characterizing thrombotic tendencies in IBD.

Main Methods:

• A cohort study involving 34 patients with CD, 29 patients with UC, and 53 healthy controls.
• Thromboelastography (TEG) was performed to determine key hemostatic parameters: R, K, α Angle, G, maximal amplitude (MA), and LY30.
• Statistical analysis was conducted to compare TEG values between IBD patient subgroups (active vs. remission) and healthy individuals.

Main Results:

• Significant differences in R, K, α Angle, G, and MA were observed between IBD patients (CD and UC) and healthy controls.
• Active CD and UC patients exhibited distinct K, α Angle, G, and MA levels compared to those in remission.
• TEG parameters (except G in CD) did not significantly differ between IBD patients in remission and healthy individuals, suggesting disease activity is a key factor.

Conclusions:

• Thrombophilic abnormalities are prevalent in Chinese IBD patients.
• TEG is a valuable tool for detecting hemostatic alterations in IBD.
• TEG may offer a new avenue for developing anticoagulant thromboprophylaxis strategies in inflammatory bowel disease.